Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma

Por Gao, Ming-zhao, Wang, Hong-bin, Chen, Xiang-ling, Cao, Wen-ting, Fu, Li, Li, Yun, Quan, Hai-tian, Xie, Cheng-ying, Lou, Li-guang
Publicado no Acta Pharmacol Sin (2018)

Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species

Por Zhong, Chen-chun, Chen, Feng, Yang, Jun-ling, Jia, Wei-wei, Li, Li, Cheng, Chen, Du, Fei-fei, Zhang, Su-ping, Xie, Cheng-ying, Zhang, Na-ting, Olaleye, Olajide E, Wang, Feng-qing, Xu, Fang, Lou, Li-guang, Chen, Dong-ying, Niu, Wei, Li, Chuan
Publicado no Acta Pharmacol Sin (2018)